enVVeno Medical Q4 EPS $(6.05) Misses $(0.30) Estimate

enVVeno Medical (NASDAQ: NVNO) reported a Q4 loss of $(6.05) per share, significantly missing the analyst estimate of $(0.30) by 1916.67%. This loss represents a 42.38% improvement compared to the $(10.50) per share loss reported in the same quarter last year.